Carlsquare: Mrkt BUZZ Elicera Therapeutics: Klinisk uppdatering om ELC-100 i linje med våra förväntningar
Igår, 16:10
Igår, 16:10
Carlsquare Equity Research har publicerat en kommentar till den kliniska uppdateringen för ELC-100-programmet.
Om Carlsquare
Carlsquare is a global research firm and financial advisor focusing on M&A, Equity
Research and Growth Equity. Carlsquare has 170 employees with deep sector knowledge in all 11
GICS sectors. The senior equity research team has extensive experience in the stock
environment and several business sectors. The team produces company research reports,
independent valuations and trading notes. The group have offices in Canada, Denmark, France, Germany, Poland, Sweden, United Kingdom and United States. Read more
Kontakter
MARKUS AUGUSTSSON
Head of Equity Research
markus.augustsson@carlsquare.com
+46 (0)76 235 03 20
NIKLAS ELMHAMMER
Senior Equity Analyst
niklas.elmhammer@carlsquare.com
+46 (0)70 898 39 59
Bifogade filer
Mrkt BUZZ Elicera Therapeutics: Klinisk uppdatering om ELC-100 i linje med våra förväntningar
Igår, 16:10
Carlsquare Equity Research har publicerat en kommentar till den kliniska uppdateringen för ELC-100-programmet.
Om Carlsquare
Carlsquare is a global research firm and financial advisor focusing on M&A, Equity
Research and Growth Equity. Carlsquare has 170 employees with deep sector knowledge in all 11
GICS sectors. The senior equity research team has extensive experience in the stock
environment and several business sectors. The team produces company research reports,
independent valuations and trading notes. The group have offices in Canada, Denmark, France, Germany, Poland, Sweden, United Kingdom and United States. Read more
Kontakter
MARKUS AUGUSTSSON
Head of Equity Research
markus.augustsson@carlsquare.com
+46 (0)76 235 03 20
NIKLAS ELMHAMMER
Senior Equity Analyst
niklas.elmhammer@carlsquare.com
+46 (0)70 898 39 59
Bifogade filer
Mrkt BUZZ Elicera Therapeutics: Klinisk uppdatering om ELC-100 i linje med våra förväntningar
Analys
Aktieråd
Bolåneräntor

Inflationen
Analys
Aktieråd
Bolåneräntor

Inflationen
1 DAG %
Senast
OMX Stockholm 30
1 DAG %
Senast
2 974,60